€200Mln Pharma and CDMO investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany About this project Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin. Investment details Park Industriepark Höchst Frankfurt-Höchst , Hessen, Germany Total area: 460.0ha Free: 50.0ha Amount € 200 mln Categories PharmaCDMO Investors Sanofi Target substances Insulin Product Related news 12 November 2015 Sanofi builds two new buildings in Höchst The drug manufacturer Sanofi plans for two buildings in Frankfurt. For this purpose the company expands with an investment in the Höchst Industrial Park. On the Höchst location Sanofi holds already...
12 November 2015 Sanofi builds two new buildings in Höchst The drug manufacturer Sanofi plans for two buildings in Frankfurt. For this purpose the company expands with an investment in the Höchst Industrial Park. On the Höchst location Sanofi holds already...
